Roche Settles Patent Row With Intas Over Cancer Drug Xeloda

Law360, New York (June 25, 2013, 4:58 PM EDT) -- A New Jersey federal judge on Monday dismissed a Hoffmann-La Roche Inc. lawsuit contending Intas Pharmaceuticals Ltd. and a subsidiary infringed a patent for Roche's Xeloda cancer drug by seeking approval for a generic version of the treatment, after the parties reached a settlement.

U.S. District Judge Esther Salas dismissed the case in a one-page order that said both parties will bear their own costs. A spokesperson for Roche Group unit Genentech told Law360 that Intas and the subsidiary, Accord Healthcare Inc. have entered a nonexclusive...
To view the full article, register now.